Your search returned 15 studies. (Get alerts for new studies):
- Vorinostat, Cisplatin, and Radiation Therapy in Treating Patients With Stage III or Stage IV Squamous Cell Cancer of the Oropharynx
Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx - Stage IV Squamous Cell Carcinoma of the Oropharynx
1 Location available
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx - Stage III Squamous Cell Carcinoma of the Larynx - Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage III Squamous Cell Carcinoma of the Nasopharynx - Stage III Squamous Cell Carcinom
9 Locations available
- Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
Conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity - Recurrent Lymphoepithelioma of the Nasopharynx - Recurrent Lymphoepithelioma of the Oropharynx - Recurrent Mucoepidermoid Carcinoma of the Oral Cavity - Recurrent Squamous Cell Carcinoma of the Hypop
1 Location available
- Phase II Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
Conditions: Head and Neck Cancer - Cancer of Nasopharynx
1 Location available
- Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell
1 Location available
- Erlotinib Hydrochloride and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed By Surgery
Conditions: Squamous Cell Carcinoma of the Skin - Stage I Squamous Cell Carcinoma of the Hypopharynx - Stage I Squamous Cell Carcinoma of the Larynx - Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage I Squamous Cell Carcinoma of the Oropharynx - Sta
1 Location available
- Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
Conditions: Cancer of the Pharynx - Cancer of the Larynx - Cancer of the Neck - Paranasal Sinus Neoplasms - Cancer of the Head
1 Location available
- Minocycline in Oropharynx Cancer
Conditions: Oropharynx Cancer
1 Location available
- Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract
Conditions: Hypopharyngeal Neoplasms - Laryngeal Neoplasms - Head and Neck Cancers - Oropharynx - Hypopharynx - Larynx
1 Location available
- Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx
Conditions: Head and Neck Cancer
1 Location available
- Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck
Conditions: Head and Neck Cancer - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Salivary Gland Cancer - Recurrent Squamous Cell Carcinoma of the Hypopharynx - R
1 Location available
- Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
Conditions: Salivary Gland Squamous Cell Carcinoma - Stage II Salivary Gland Cancer - Stage II Squamous Cell Carcinoma of the Hypopharynx - Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity - Stage II Squamous Cell Carcinoma of the Oropharynx - Stage II Ver
1 Location available
- Intensity-Modulated Radiation Therapy, Pemetrexed Disodium, and Erlotinib Hydrochloride in Treating Patients With Recurrent or Second Primary Head and
Conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Squamous Cell Carcinoma of the Hypopharynx - Recurrent Squamous Cell Carcinoma of the Larynx - Recurren
2 Locations available
|